HIV report
New Novotech Report Finds 1,000 HIV Clinical Trials Globally
28 déc. 2023 21h49 HE | Novotech
Novotech today released the latest 2023 global clinical trial landscape report on HIV, a condition now affecting more than 39 million people.
Global Biosensors Market
Global Biosensors Market Analysis Report 2024-2030, Featuring Key Players Bio-Rad Laboratories, Medtronic, Nova Biomedical, TDK and Siemens Healthcare
20 déc. 2023 09h08 HE | Research and Markets
Dublin, Dec. 20, 2023 (GLOBE NEWSWIRE) -- The "Global Biosensors Market Size, Share & Trends Analysis Report by Technology (Electrochemical, Thermal, Piezoelectric), Application (Medical,...
Global Microfluidics Market
Microfluidics Markets: Proteomic, Genomic, Cell-based, Capillary - Global Forecast to 2028
13 déc. 2023 09h39 HE | Research and Markets
Dublin, Dec. 13, 2023 (GLOBE NEWSWIRE) -- The "Global Microfluidics Market by Product (Device, Component (Chip, Sensor, Microneedle, Pump, Valve), Application (IVD (POC, Clinical, Vet), Research...
CG-LOGO-Vertical-Compact.png
Conjugate Group Expands Services with Strategic Addition of Executive Search
08 déc. 2023 11h18 HE | The Conjugate Group, LLC
Conjugate Group Expands Services with Strategic Addition of Executive Search
Logo.png
Hepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value and Management Changes
07 déc. 2023 08h00 HE | Hepion Pharmaceuticals, Inc.
Restructuring program purpose is to preserve capital and optimize clinical development program Management plans to continue to evaluate its Phase 2b ASCEND-NASH clinical trial taking in account...
NOVARTIS logo.jpg
Novartis receives FDA approval for Fabhalta® (iptacopan), offering superior hemoglobin improvement in the absence of transfusions as the first oral monotherapy for adults with PNH
05 déc. 2023 19h16 HE | Novartis Pharma AG
Ad hoc announcement pursuant to Art. 53 LR Approval based on APPLY-PNH trial in adults with PNH and anemia despite prior anti-C5 treatment, and supported by the APPOINT-PNH study in complement...
Verge Logo.png
Verge Genomics Will Use Modality.AI in Its ALS Phase 1b Clinical Trial of Its Lead Drug Candidate VRG50635
29 nov. 2023 07h00 HE | Verge Genomics
SOUTH SAN FRANCISCO, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Verge Genomics, a clinical-stage biotechnology company transforming drug discovery using artificial intelligence and human data,...
Global Life Sciences BPO Market
Life Sciences BPO Market Size, Share & Trends Analysis Report 2023: Pharmaceutical Outsourcing, Medical Devices Outsourcing, Contract Sales and Marketing Outsourcing - Global Forecast to 2030
27 nov. 2023 06h18 HE | Research and Markets
Dublin, Nov. 27, 2023 (GLOBE NEWSWIRE) -- The "Life Sciences BPO Market Size, Share & Trends Analysis Report By Services (Pharmaceutical Outsourcing, Medical Devices Outsourcing, Contract Sales...
Transparency Market Research
Research Antibodies and Reagents Market to Reach USD 23 billion, at a 6.6% CAGR by 2033 - Transparency Market Research Inc.
23 nov. 2023 09h30 HE | Transparency Market Research
Wilmington, Delaware, United States, Nov. 23, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global research antibodies and reagents market is projected to flourish at a CAGR of...
SAGALIAM ACQUISITION CORP. ANNOUNCES A TEMPORARY RESTRAINING ORDER ON ITS EXTENSION PROXY SHAREHOLDER MEETING
20 nov. 2023 17h15 HE | Sagaliam Acquisition Corp
New York, NY, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: “SAGAU”, “SAGA”, “SAGAR”) (“we”, “us”, “our”, or the “Company”) announced today that it received a Temporary...